申请人:Guillemont Jerôme Emile Georges
公开号:US20100016317A1
公开(公告)日:2010-01-21
HIV replication inhibitors of formula
R
1
is hydrogen; aryl; formyl; C
1-6
alkylcarbonyl; C
1-6
alkyl; C
1-6
alkyloxycarbonyl;
R
2
, R
3
, R
6
and R
7
are hydrogen; hydroxy; halo; C
3-7
cycloalkyl; C
1-6
alkyloxy; carboxyl; C
1-6
alkyloxycarbonyl; cyano; nitro; amino; mono- or di(C
1-6
alkyl)amino; polyhaloC
1-6
alkyl; polyhaloC
1-6
alkyloxy; —C(═O)R
9
; optionally substituted C
1-6
alkyl, C
2-6
alkenyl or C
2-6
alkynyl;
R
4
and R
5
are hydroxy; halo; C
3-7
cycloalkyl; C
1-6
alkyloxy; carboxyl; C
1-6
alkyloxycarbonyl; formyl; cyano; nitro; amino; mono- or di(C
1-6
alkyl)amino; polyhaloC
1-6
alkyl; polyhaloC
1-6
alkyloxy; —C(═O)R
9
; cyano; —S(═O)
r
R
9
; —NH—S(═O)
2
R
9
; —NHC(═O)H; —C(═O)NHNH
2
; —NHC(═O)R
9
; Het; —Y-Het; optionally substituted C
1-6
alkyl, C
2-6
alkenyl or C
2-6
alkynyl;
R
5
is pyridyl, —C(═O)NR
5a
R
5b
; —CH(OR
5c
)R
5d
; —CH
2
—NR
5e
R
5f
; —CH═NOR
5a
; —CH
2
—O—C
2-6
alkenyl; —CH
2
—O—P(═O)(OR
5g
)
2
; —CH
2
—O—C(═O)—NH
2
; —C(═O)—R
5d
;
X is —NR
1
—, —O—, —CH
2
—, —S—;
pharmaceutical compositions containing these compounds as active ingredient and processes for preparing said compounds and compositions.